JP2013136639A5 - - Google Patents

Download PDF

Info

Publication number
JP2013136639A5
JP2013136639A5 JP2013079295A JP2013079295A JP2013136639A5 JP 2013136639 A5 JP2013136639 A5 JP 2013136639A5 JP 2013079295 A JP2013079295 A JP 2013079295A JP 2013079295 A JP2013079295 A JP 2013079295A JP 2013136639 A5 JP2013136639 A5 JP 2013136639A5
Authority
JP
Japan
Prior art keywords
groups
oligosaccharide
group
aryl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013079295A
Other languages
English (en)
Japanese (ja)
Other versions
JP5699174B2 (ja
JP2013136639A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013136639A publication Critical patent/JP2013136639A/ja
Publication of JP2013136639A5 publication Critical patent/JP2013136639A5/ja
Application granted granted Critical
Publication of JP5699174B2 publication Critical patent/JP5699174B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013079295A 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原 Expired - Fee Related JP5699174B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67828905P 2005-05-06 2005-05-06
US60/678,289 2005-05-06

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008509538A Division JP2008540398A (ja) 2005-05-06 2006-05-08 髄膜炎a型ワクチンのための免疫原

Publications (3)

Publication Number Publication Date
JP2013136639A JP2013136639A (ja) 2013-07-11
JP2013136639A5 true JP2013136639A5 (enExample) 2014-03-06
JP5699174B2 JP5699174B2 (ja) 2015-04-08

Family

ID=36942242

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008509538A Withdrawn JP2008540398A (ja) 2005-05-06 2006-05-08 髄膜炎a型ワクチンのための免疫原
JP2013079295A Expired - Fee Related JP5699174B2 (ja) 2005-05-06 2013-04-05 髄膜炎a型ワクチンのための免疫原

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008509538A Withdrawn JP2008540398A (ja) 2005-05-06 2006-05-08 髄膜炎a型ワクチンのための免疫原

Country Status (15)

Country Link
US (1) US8062641B2 (enExample)
EP (1) EP1885734B1 (enExample)
JP (2) JP2008540398A (enExample)
CN (1) CN101282984B (enExample)
AU (1) AU2006245440B2 (enExample)
BR (1) BRPI0611447A2 (enExample)
CA (1) CA2606890C (enExample)
ES (1) ES2533248T3 (enExample)
MX (1) MX2007013881A (enExample)
NZ (1) NZ563940A (enExample)
PL (1) PL1885734T3 (enExample)
PT (1) PT1885734E (enExample)
RU (1) RU2412944C2 (enExample)
WO (1) WO2006120576A2 (enExample)
ZA (1) ZA200710558B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
US9486515B2 (en) 2005-06-27 2016-11-08 Glaxosmithkline Biologicals S.A. Immunogenic composition
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
GB0700562D0 (en) * 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
AU2014200640B2 (en) * 2007-01-11 2016-06-16 Glaxosmithkline Biologicals Sa Modified saccharides
KR101646960B1 (ko) 2007-10-16 2016-08-09 프로젠 피지500 시리즈 피티와이 리미티드 신규한 황산화된 올리고사카라이드 유도체
PL3831406T3 (pl) 2010-08-23 2024-09-09 Wyeth Llc Stabilne preparaty antygenów rLP2086 Neisseria meningitidis
US9057716B2 (en) 2010-09-04 2015-06-16 Novartis Ag Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines
RU2546873C2 (ru) 2010-09-10 2015-04-10 УАЙТ ЭлЭлСи Нелипидизированные варианты антигенов neisseria meningitidis orf2086
CN102417521B (zh) * 2010-09-28 2014-05-07 中国医学科学院医药生物技术研究所 一种非环核苷类抗病毒药物磷酸单酯化合物的制备方法
WO2012103444A2 (en) * 2011-01-28 2012-08-02 Purdue Research Foundation Immunogenic compositions and reagents for preparing
IN2014DN00168A (enExample) * 2011-07-12 2015-05-22 Gen Hospital Corp
RU2476444C1 (ru) * 2011-07-15 2013-02-27 Российская Федерация, от имени которой выступает Министерство промышленности и торговли Российской Федерации (Минпромторг России) СПОСОБ ПОЛУЧЕНИЯ КОНЪЮГАТА НОНА-β-(1→3)-ГЛЮКОЗИДА С БЫЧЬИМ СЫВОРОТОЧНЫМ АЛЬБУМИНОМ СКВАРАТНЫМ МЕТОДОМ
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
MY167723A (en) 2012-03-09 2018-09-21 Pfizer Neisseria meningitidis compositions and methods thereof
WO2014130613A2 (en) * 2013-02-22 2014-08-28 Amgen Inc. Carbohydrate phosphonate derivatives as modulators of glycosylation
US9802987B2 (en) 2013-03-08 2017-10-31 Pfizer Inc. Immunogenic fusion polypeptides
CA2917365A1 (en) * 2013-07-07 2015-01-15 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Synthetic vaccines against streptococcus pneumoniae type 1
EP4098276A1 (en) 2013-09-08 2022-12-07 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
CN106061986B (zh) * 2014-02-25 2020-07-07 默沙东和惠康基金会合资的希勒曼实验室私人有限公司 脑膜炎奈瑟菌血清组x的新的合成寡聚体及其制备方法
EA201700177A1 (ru) * 2014-10-09 2017-07-31 Мсд Уэлком Траст Хиллеман Лабораторис Пвт. Лтд. Улучшенный способ конъюгирования и полученные с помощью него новые синтетические конъюгаты олигосахарида с белком
US10888611B2 (en) 2015-02-19 2021-01-12 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
AU2017321863B2 (en) 2016-09-02 2024-07-11 Sanofi Vaccines US Inc. Neisseria meningitidis vaccine
PE20191107A1 (es) 2017-01-31 2019-08-26 Pfizer Composiciones de neisseria meningitidis y metodos respectivos
WO2018173068A1 (en) * 2017-03-21 2018-09-27 Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. A novel synthetic neisseria meningitidis serogroup a oligomer and process for synthesizing thereof
US12187756B2 (en) 2018-11-22 2025-01-07 Idorsia Pharmaceuticals Ltd Stable vaccine against Clostridium difficile
WO2021059181A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
CN118178643B (zh) * 2024-04-28 2024-11-29 亚培烯科技(上海)有限公司 饱和α烯烃低聚物作为佐剂在动物疫苗中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US6114309A (en) * 1997-11-21 2000-09-05 Incara Research Laboratories Combinatorial library of moenomycin analogs and methods of producing same
JP4774496B2 (ja) * 2001-06-14 2011-09-14 独立行政法人産業技術総合研究所 α−マンノシダーゼ
WO2003080678A1 (en) * 2002-03-26 2003-10-02 Chiron Srl Modified saccharides having improved stability in water
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
DK1587537T3 (da) * 2003-01-30 2012-07-16 Novartis Ag Injicerbare vacciner mod multiple meningococ-serogrupper
RU2250113C2 (ru) * 2003-06-04 2005-04-20 Институт биоорганической химии им. академиков М.М.Шемякина и Ю.А.Овчинникова Российской академии наук Способ приготовления бивалентной вакцины для профилактики менингококковой инфекции

Similar Documents

Publication Publication Date Title
JP2013136639A5 (enExample)
JP2008540398A5 (enExample)
RU2412944C2 (ru) Иммуногены для вакцин против менингита а
JP2012017342A5 (enExample)
JP2014218516A5 (enExample)
US11147872B2 (en) Multivalent glycoconjugate vaccines
JP2010515718A5 (enExample)
KR102634811B1 (ko) 면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
JP2010132925A5 (enExample)
JP2020533438A5 (enExample)
JP2020533442A5 (enExample)
EA200801935A1 (ru) Конъюгатные вакцины
JP2013079285A5 (enExample)
JP2020533439A5 (enExample)
AU2013237497B2 (en) Carbohydrate-glycolipid conjugate vaccines
EA201391788A1 (ru) Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
JP2011528710A5 (enExample)
NO20082646L (no) Vaksine
Enotarpi et al. A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
US10729763B2 (en) Mixtures of polysaccharide-protein pegylated compounds
JP2017532321A5 (enExample)
JP6416249B2 (ja) ストレプトコッカス ニューモニエ1型に対する合成ワクチン
JP2023537945A (ja) 出現血清型24fを含む多価肺炎球菌複合糖質ワクチン
JP6630440B2 (ja) ストレプトコッカス ニューモニアエ(Streptococcus pneumoniae)血清型2に対する合成ワクチン
JP2017537941A5 (enExample)